Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Joo‐Yeon Chung"'
Autor:
Se‐Hoon Lee, Yeongmin Kim, Bu‐Nam Jeon, Gihyeon Kim, Jinyoung Sohn, Youngmin Yoon, Sujeong Kim, Yunjae Kim, Hyemin Kim, Hongui Cha, Na‐Eun Lee, Hyunsuk Yang, Joo‐Yeon Chung, A‐Reum Jeong, Yun Yeon Kim, Sang Gyun Kim, Yeonhee Seo, Sehhoon Park, Hyun Ae Jung, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Hansoo Park, Kyoung Wan Yoon
Publikováno v:
Advanced Science, Vol 10, Iss 17, Pp n/a-n/a (2023)
Abstract Immune checkpoint inhibitor (ICI) clinically benefits cancer treatment. However, the ICI responses are only achieved in a subset of patients, and the underlying mechanisms of the limited response remain unclear. 160 patients with non‐small
Externí odkaz:
https://doaj.org/article/4ff970230138448ab38c9661f2b162ca
Autor:
Se Ik Kim, Joo Yeon Chung, Haerin Paik, Aeran Seol, Soon Ho Yoon, Taek Min Kim, Hee Seung Kim, Hyun Hoon Chung, Jeong Yeon Cho, Jae-Weon Kim, Maria Lee
Publikováno v:
Insights into Imaging, Vol 12, Iss 1, Pp 1-11 (2021)
Abstract Objectives To investigate the impact of computed tomography (CT)-based, artificial intelligence-driven waist skeletal muscle volume on survival outcomes in patients with endometrial cancer. Methods We retrospectively identified endometrial c
Externí odkaz:
https://doaj.org/article/f34a8aebfd8a4dc09c9130c20f956602
Autor:
Hee Seung Kim, Jae Weon Kim, Hyun Hoon Chung, Ga Won Yim, Noh Hyun Park, Aeran Seol, Yong Sang Song, Se Ik Kim, Joo Yeon Chung, Maria Lee
Publikováno v:
Cancer Research and Treatment. 54:1219-1229
Purpose This study aimed to identify patients who would benefit from third and subsequent lines of chemotherapy in recurrent epithelial ovarian cancer (EOC).Materials and Methods Recurrent EOC patients who received third, fourth, or fifth-line pallia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57370f30092db193debef9f566320a12
https://doi.org/10.4143/crt.2021.1010
https://doi.org/10.4143/crt.2021.1010
Autor:
Dong Won, Hwang, Eun Ji, Lee, Joo Yeon, Chung, Eun Joo, Lee, Dayoung, Kim, Soo Hyun, Oh, Seungmee, Lee, Ga Won, Yim, Seung-Hyuk, Shim, Sung Jong, Lee, San-Hui, Lee, Ji Won, Park, Suk-Joon, Chang, Kyung Ah, Pak, Soo Jin, Park, Hee Seung, Kim, On Behalf Of The KoRIA Trial Group
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 11; Pages: 1799
Even though rotational intraperitoneal pressurized aerosol chemotherapy (RIPAC) has been developed to improve the distribution and penetration depth of anti-cancer agents by pressurized intraperitoneal aerosol chemotherapy (PIPAC), the optimal nozzle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::919f477b701f71590a212b0de716aa15
https://pubmed.ncbi.nlm.nih.gov/36579527
https://pubmed.ncbi.nlm.nih.gov/36579527
Autor:
Hyunkyung Yu, Nathalie Bellocq, Youngeun Ha, Hyunuk Kim, Yunyeon Kim, Bu-Nam Jeon, Léo Marx, Mathilde Pantin, Hyunjin Yoo, Seungmin Byun, Joo-Yeon Chung, Mi Young Cha, Patrick Garrouste, Frédéric Lévy
Publikováno v:
Cancer Research. 82:1760-1760
Antibody-drug conjugates (ADCs) are considered as promising cancer treatment modalities that combine the selectivity of antibodies and the cytotoxic properties of payloads using chemical linkers. However, despite their success, ADCs still suffer from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aad5ed0031573811a4b4774b06731d7
https://doi.org/10.1158/1538-7445.am2022-1760
https://doi.org/10.1158/1538-7445.am2022-1760
Autor:
Mi Young Cha, Bu-Nam Jeon, Hyunsuk Yang, Seungmin Byun, Areum Jeong, Joo-Yeon Chung, Sanggyun Kim, Kyung Mi Park, Hansoo Park
Publikováno v:
Cancer Research. 82:592-592
TLT2 (TREML2, Triggering Receptor Expressed on Myeloid cells Like transcript 2) is a single-pass type I membrane protein that contains an immunoglobulin-like domain. Previous studies have shown that TLT2 is up-regulated in response to inflammation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01737b6072004befd6a84a1de0c7bbcf
https://doi.org/10.1158/1538-7445.am2022-592
https://doi.org/10.1158/1538-7445.am2022-592
Autor:
Mi Young Cha, Hnkyung yu, Bu-Nam Jeon, Hyunuk Kim, Youngeun Ha, Yunyeon Kim, Joo-Yeon Chung, Soojung Moon, Hyunseong Youn, Han-sol Kim, Kyung Mi Park, Hansoo Park
Publikováno v:
Cancer Research. 82:2862-2862
The immunotherapeutic treatment has profoundly improved the clinical outcomes in patients with advanced cancers. However, most patients still have not responded to immune checkpoint inhibitor (ICI) treatment. Thus, it is still urgent to find novel tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2910ea59018f913767fd50ef11985233
https://doi.org/10.1158/1538-7445.am2022-2862
https://doi.org/10.1158/1538-7445.am2022-2862
Autor:
Jong Min An, Jungyo Suh, Jaehoon Kim, Youngwoong Kim, Joo Yeon Chung, Hee Seung Kim, Sung Yong Cho, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Chang Wook Jeong, Dokyoung Kim
Publikováno v:
Sensors and Actuators B: Chemical. 360:131646
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8b45b8a5ef309703a8f24cc8ac64d22
https://doi.org/10.1016/j.snb.2022.131646
https://doi.org/10.1016/j.snb.2022.131646
Autor:
Aeran Seol, Ga Won Yim, Joo Yeon Chung, Se Ik Kim, Lee, Maria, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong Sang Song
Publikováno v:
Cancer Research & Treatment; Oct2022, Vol. 54 Issue 4, p1219-1229, 11p
Autor:
Joo-Yeon Chung, Yun Yeon Kim, Hyunuk Kim, Mi Young Cha, Kyung Mi Park, Youn Kyung Houh, Hansoo Park
Publikováno v:
Cancer Research. 81:688-688
Vast improvements in tumor treatment have been achieved with immune checkpoint inhibitors. They have been approved for use in monotherapy or combinations for patients with different types of cancer. However, the treatments often yield limited benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ad4c55cef5b757f660c9ab368fc847d
https://doi.org/10.1158/1538-7445.am2021-688
https://doi.org/10.1158/1538-7445.am2021-688